PAGANINI BIOPHARMA
Paganini Biopharma is a development stage biotechnology company that is focused on therapeutics for cancer. The first product is a unique human monoclonal antibody that targets breast cancer stem cells and is being developed for triple negative breast cancer.
PAGANINI BIOPHARMA
Industry:
Biotechnology Health Care
Founded:
2008-01-01
Address:
Encino, California, United States
Country:
United States
Status:
Active
Similar Organizations
Linnaeus Therapeutics
Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.
Patrys
Patrys is a clinical-stage biotechnology company focused on therapies for human cancers.
Stellanova Therapeutics
Stellanova Therapeutics is a private, development-stage biotechnology company that focuses on cancer therapies
More informations about "Paganini Biopharma"
Paganini Biopharma 2025 Company Profile: Valuation, Investors ...
Information on acquisition, funding, investors, and executives for Paganini Biopharma. Use the PitchBook Platform to explore the full profile.See details»
Paganini Biopharma - Products, Competitors, Financials, …
Paganini Biopharma is a biotechnology company working on the development of cancer-fighting therapeutics. Use the CB Insights Platform to explore Paganini Biopharma's full profile.See details»
Paganini Biopharma Inc | www.inknowvation.com
Spun out of UCLA, Paganini Biopharma, Inc. had been a development stage biotechnology company focused on therapeutics for cancer. The firm was acquired in 2017 by …See details»
Paganini Biopharma Inc - Company Profile and News
Company profile page for Paganini Biopharma Inc including stock price, company news, executives, board members, and contact informationSee details»
Paganini Biopharma - Crunchbase
Paganini Biopharma is a development stage biotechnology company that is focused on therapeutics for cancer.See details»
Paganini Biopharma, Inc - Company Profile - Corporation Wiki
View company leaders and background information for Paganini Biopharma, Inc. Search our database of over 100 million company and executive profiles.See details»
Paganini Biopharma Inc Company Profile, Financial and ... - digitGaps
DigitGaps report on Paganini Biopharma Inc delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses and structures, and …See details»
Paganini Biopharma, Inc.:Company Profile & Technical Research ...
Paganini Biopharma, Inc. is a company that provides Breast cancer stem cell, Biotechnology, Triple-negative breast cancer and more. Paganini Biopharma, Inc. is headquartered in United …See details»
Paganini Biopharma, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Paganini Biopharma, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Paganini Biopharma, Inc. - Party | RPX Insight
Paganini Biopharma, Inc. has 0 patent litigation cases (0 cases currently active) - 0 patents asserted - 0 cases as a plaintiff - 0 cases as a defendantSee details»
OncoResponse Buys Paganini Biopharma to Add Cancer Drug to …
Houston--OncoResponse has acquired biotech startup Paganini Biopharma in a move that brings a clinical trial-ready compound to the Houston cancer drug developer. No financial terms were …See details»
OncoResponse Acquires Paganini Biopharma | American …
Nov 7, 2017 OncoResponse has closed the acquisition of Paganini Biopharma, acquiring all of its assets including an anti-epithelial membrane protein 2 (EMP2) fully human monoclonal …See details»
Paganini Biopharma, Inc. Reviews | Read Client Reviews of Paganini ...
Paganini Biopharma, Inc. offers great opportunities for growth and personal development. I am grateful to be a part of this organization and would highly recommend it to anyone looking for a …See details»
Articles about Paganini Biopharma - BioSpace
Paganini Biopharma is a development stage biotechnology company that is focused on therapeutics for cancer.See details»
Paganini Biopharma - Tech Stack, Apps, Patents & Trademarks
Paganini Biopharma is a development stage biotechnology company that is focused on therapeutics for cancer.See details»
OncoResponse : Adds Anti-EMP2 Antibody to Oncology Pipeline …
Nov 7, 2017 OncoResponse today announced that it has closed the acquisition of Paganini Biopharma, acquiring all of its assets including an anti-epithelial membrane protein 2 (EMP2) …See details»
OncoResponse Adds Anti-EMP2 Antibody to Oncology Pipeline
Nov 7, 2017 OncoResponse today announced that it has closed the acquisition of Paganini Biopharma, acquiring all of its assets including an anti-epithelial membrane protein 2 (EMP2) …See details»
OncoResponse Adds Anti-EMP2 Antibody to Oncology Pipeline
Nov 7, 2017 Paganini Biopharma was founded on technology originated in the Department of Pathology and Laboratory Medicine of the School of Medicine at UCLA under a license …See details»
Simplification for success: Rewiring the biopharma operating model
3 days ago Some organizations have successfully simplified their structures by eliminating duplication between global, regional, and local layers. One biopharma company consolidated …See details»
OncoResponse acquires Paganini Biopharma - 2017-11-07
Nov 7, 2017 Paganini Biopharma Paganini Biopharma is a development stage biotechnology company that is focused on therapeutics for cancer.See details»